Induced clustered nanoconfinement of superparamagnetic iron oxide in biodegradable nanoparticles enhances transverse relaxivity for targeted theranostics.
Induced clustered nanoconfinement of superparamagnetic iron oxide in biodegradable nanoparticles enhances transverse relaxivity for targeted theranostics.
复制标题
DOI:
10.1002/mrm.24622
复制
发表时间:
2013-12
影响因子:
3.3
通讯作者:
Fahmy, Tarek M.
中科院分区:
文献类型:
--
作者:
Ragheb, Ragy R. T.;Kim, Dongin;Bandyopadhyay, Arunima;Chahboune, Halima;Bulutoglu, Beyza;Ezaldein, Harib;Criscione, Jason M.;Fahmy, Tarek M.
Combined therapeutic and diagnostic agents, “theranostics” are emerging valuable tools for noninvasive imaging and drug delivery. Here, we report on a solid biodegradable multifunctional nanoparticle that combines both features. Poly(lactide-co-glycolide) nanoparticles were engineered to confine superparamagnetic iron oxide contrast for magnetic resonance imaging while enabling controlled drug delivery and targeting to specific cells. To achieve this dual modality, fatty acids were used as anchors for surface ligands and for encapsulated iron oxide in the polymer matrix. We demonstrate that fatty acid modified iron oxide prolonged retention of the contrast agent in the polymer matrix during degradative release of drug. Antibody-fatty acid surface modification facilitated cellular targeting and subsequent internalization in cells while inducing clustering of encapsulated fatty-acid modified superparamagnetic iron oxide during particle formulation. This induced clustered confinement led to an aggregation within the nanoparticle and, hence, higher transverse relaxivity, r2, (294 mM−1 s−1) compared with nanoparticles without fatty-acid ligands (160 mM−1 s−1) and higher than commercially available superparamagnetic iron oxide nanoparticles (89 mM−1 s−1). Clustering of superparamagnetic iron oxide in poly(lactide-co-glycolide) did not affect the controlled release of encapsulated drugs such as methotrexate or clodronate and their subsequent pharmacological activity, thus highlighting the full theranostic capability of our system.
登录
查看更多内容
影响因子:
10.8
作者:
Kester M;Heakal Y;Fox T;Sharma A;Robertson GP;Morgan TT;Altinoğlu EI;Tabaković A;Parette MR;Rouse SM;Ruiz-Velasco V;Adair JH
通讯作者:
Adair JH
影响因子:
10.8
作者:
Nasongkla, Norased;Bey, Erik;Gao, Jinming
通讯作者:
Gao, Jinming
影响因子:
15
作者:
Pan, Dipanjan;Caruthers, Shelton D.;Lanza, Gregory M.
通讯作者:
Lanza, Gregory M.
影响因子:
4.9
作者:
Guthi JS;Yang SG;Huang G;Li S;Khemtong C;Kessinger CW;Peyton M;Minna JD;Brown KC;Gao J
通讯作者:
Gao J
影响因子:
14
作者:
Lee, Eddy S. M.;Shuter, Borys;Wang, Shih-Chang
通讯作者:
Wang, Shih-Chang